4AB:FRA
AbbVie
230,10 €
arrow_downward
-0,39%(-0,90) 1K
1-okt, 8:01:32 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto4AB tikeri uchun statistika yaratilmoqda...
Ochish
230,10 €
Yuqori
230,10 €
Past
230,10 €
Bozor kapitali
462,26 mlrd
Oʻrtacha hajm
47,00
Hajmi
0,00
52 haftalik eng yuqori
235,70 €
52 haftalik eng past
167,55 €
Xodimlar soni
57 ming
Ochish
230,10 €
Yuqori
230,10 €
Past
230,10 €
Bozor kapitali
462,26 mlrd
Oʻrtacha hajm
47,00
Hajmi
0,00
52 haftalik eng yuqori
235,70 €
52 haftalik eng past
167,55 €
Xodimlar soni
57 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Pluang
·
10 daqiqa oldin
AbbVie to release Q3 2026 earnings on Oct 30 be...
TradingView
·
26 daqiqa oldin
AbbVie to Host Third-Quarter 2026 Earnings Conference Call
AD HOC NEWS
·
6 soat oldin
AbbVie stock pre-market at EUR 231.40: minus 0.09 percent
The Motley Fool
·
18 soat oldin
AbbVie Stock: Buy, Sell, or Hold in October?
Profil
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
AbbVie haqida
CEORobert A. Michael
Xodimlar soni57 ming
Asos solingan10-apr, 2012
Bosh ofislarNorth Chicago, Illinoys, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytabbvie.com